ArticleCurrent oncology (Toronto, Ont.)2024

Longitudinal Assessment of FT3 to FT4 Conversion Ratio in Predicting the Efficacy of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small Cell Lung Cancer: A Propensity-Score Matching Analysis of Data from the National Drug Monitoring Agency.

Fabrizio Nelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.